Cargando…

A Novel Homozygous Mutation in the COL4A4 Gene (Gly1436del) Causing Alport Syndrome Exposed by Pregnancy: A Case Report and Review of the Literature

BACKGROUND: Alport syndrome results from a hereditary defect of collagen IV synthesis. This causes progressive glomerular disease, ocular abnormalities, and inner ear impairment. Case Presentation. Herein, we present a case of Alport syndrome in a 28-year-old woman caused by a novel mutation (Gly143...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jehn, Ulrich, Müller-Hofstede, Cornelie, Heitplatz, Barbara, Van Marck, Veerle, Reuter, Stefan, Pavenstädt, Hermann, George, Britta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752291/ https://www.ncbi.nlm.nih.gov/pubmed/35028164 http://dx.doi.org/10.1155/2022/5243137

Ejemplares similares

Genotype–phenotype correlations for COL4A3–COL4A5 variants resulting in Gly substitutions in Alport syndrome
por: Gibson, Joel T., et al.
Publicado: (2022)

A Low Tacrolimus Concentration/Dose Ratio Increases the Risk for the Development of Acute Calcineurin Inhibitor-Induced Nephrotoxicity
por: Thölking, Gerold, et al.
Publicado: (2019)

Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome
por: Liu, Jian-Hong, et al.
Publicado: (2017)

COL4A6 is dispensable for autosomal recessive Alport syndrome
por: Murata, Tomohiro, et al.
Publicado: (2016)

Identification of 27 Novel Variants in Genes COL4A3, COL4A4, and COL4A5 in Lithuanian Families With Alport Syndrome
por: Cerkauskaite, Agne, et al.
Publicado: (2022)

Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X‐linked Alport syndrome
por: Zhang, Yanqin, et al.
Publicado: (2019)

α-Galactosidase a Deficiency in Fabry Disease Leads to Extensive Dysregulated Cellular Signaling Pathways in Human Podocytes
por: Jehn, Ulrich, et al.
Publicado: (2021)

Novel mutations of COL4A3, COL4A4, and COL4A5 genes in Chinese patients with Alport Syndrome using next generation sequence technique
por: Zhao, Xuechao, et al.
Publicado: (2019)

First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient
por: Jehn, Ulrich, et al.
Publicado: (2022)

Trimerization and Genotype–Phenotype Correlation of COL4A5 Mutants in Alport Syndrome
por: Kamura, Misato, et al.
Publicado: (2020)

Novel heterozygous mutation in COL4A4 responsible for Alport syndrome in a Chinese family
por: Du, Ran, et al.
Publicado: (2022)

New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells
por: Daga, Sergio, et al.
Publicado: (2019)

Clinical Manifestations of Alport Syndrome-Diffuse Leiomyomatosis Patients With Contiguous Gene Deletions in COL4A6 and COL4A5
por: Zhou, Xi, et al.
Publicado: (2021)

Should We Diagnose Autosomal Dominant Alport Syndrome When There Is a Pathogenic Heterozygous COL4A3 or COL4A4 Variant?
por: Savige, Judy
Publicado: (2018)

Creation of X-linked Alport syndrome rat model with Col4a5 deficiency
por: Namba, Masumi, et al.
Publicado: (2021)

The Contribution of COL4A5 Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome
por: Yamamura, Tomohiko, et al.
Publicado: (2022)

The Hypomorphic Variant p.(Gly624Asp) in COL4A5 as a Possible Cause for an Unexpected Severe Phenotype in a Family With X-Linked Alport Syndrome
por: Macheroux, Eva Pauline, et al.
Publicado: (2019)

Belatacept as a Treatment Option in Patients with Severe BK Polyomavirus Infection and High Immunological Risk—Walking a Tightrope between Viral Control and Prevention of Rejection
por: Jehn, Ulrich, et al.
Publicado: (2022)

Novel Therapeutic Strategies for Dyslipidemia: First Report of Inclisiran Therapy in a Kidney Transplanted Patient
por: Ueberdiek, Lars, et al.
Publicado: (2023)

Corrigendum: Novel Therapeutic Strategies for Dyslipidemia: First Report of Inclisiran Therapy in a Kidney Transplanted Patient
por: Ueberdiek, Lars, et al.
Publicado: (2023)

Alport syndrome caused by a COL4A5 deletion and exonization of an adjacent AluY
por: Nozu, Kandai, et al.
Publicado: (2014)

Genotype-Phenotype Correlations for Pathogenic COL4A3–COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome
por: Savige, Judy, et al.
Publicado: (2022)

Alport Syndrome: De Novo Mutation in the COL4A5 Gene Converting Glycine 1205 to Valine
por: Antón-Martín, Pilar, et al.
Publicado: (2012)

Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5
por: Yamamura, Tomohiko, et al.
Publicado: (2020)

The First COL4A5 Exon 41A Glycine Substitution in a Family With Alport Syndrome
por: Wang, Fang, et al.
Publicado: (2020)

Publisher Correction: Creation of X-linked Alport syndrome rat model with Col4a5 deficiency
por: Namba, Masumi, et al.
Publicado: (2021)

Genetic and molecular dynamics analysis of two variants of the COL4A5 gene causing Alport syndrome
por: Liang, Lei, et al.
Publicado: (2023)

Autosomal recessive Alport syndrome caused by a novel COL4A4 splice site mutation: a case report
por: Šenjug, Petar, et al.
Publicado: (2019)

Potential Founder Variants in COL4A4 Identified in Bukharian Jews Linked to Autosomal Dominant and Autosomal Recessive Alport Syndrome
por: Levy, Michal, et al.
Publicado: (2023)

A family case of X-linked Alport syndrome patients with a novel variant in COL4A5
por: Kashiwagi, Yasuyo, et al.
Publicado: (2018)

Low frequency of parental mosaicism in de novo COL4A5 mutations in X‐linked Alport syndrome
por: Helle, Ole Magnus Bjorgaas, et al.
Publicado: (2020)

Compound Mutations of the COL4A3 including a Novel Allele Identified in a Patient with Alport Syndrome
por: Wang, Zhendong, et al.
Publicado: (2020)

A glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport syndrome
por: Odiatis, Christoforos, et al.
Publicado: (2020)

Novel Mutations of COL4A5 Identified in Chinese Families with X-Linked Alport Syndrome and Literature Review
por: Gong, Wen-yu, et al.
Publicado: (2021)

A Case Report of COL4A5 Gene Mutation Alport Syndrome in 2 Native African Children
por: Oduware, Emmanuel, et al.
Publicado: (2021)

A mouse model for X-linked Alport syndrome induced by Del-ATGG in the Col4a5 gene
por: Wu, Wei-qing, et al.
Publicado: (2023)

Case report: A case report of Alport syndrome caused by a novel mutation of COL4A5
por: Pan, Shujun, et al.
Publicado: (2023)

Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients
por: Jehn, Ulrich, et al.
Publicado: (2021)

Fast Tacrolimus Metabolism Does Not Promote Post-Transplant Diabetes Mellitus after Kidney Transplantation
por: Jehn, Ulrich, et al.
Publicado: (2022)

Heterozygous Pathogenic COL4A3 and COL4A4 Variants (Autosomal Dominant Alport Syndrome) Are Common, and Not Typically Associated With End-Stage Kidney Failure, Hearing Loss, or Ocular Abnormalities
por: Savige, Judy
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_35unptt328vho761prl55o2jml